4D Molecular Therapeutics FDMT Deferred Revenue — Deferred Revenue

Similar metrics at other companies

CNKOther Deferred Revenues — Deferred Revenue

$261.1M+5.8%

EXTROther Deferred Revenue — Deferred Revenue

$14.13M-30.6%

STXSProduct Shipped Revenue Deferred — Deferred Revenue

$781K-56.4%

BTBTOther Revenue — Deferred Revenue

$2.79M—

DJCODeferred Maintenance Agreement — Deferred Revenue

$13.48M—

OOMAProduct — Deferred Revenue

$80K+1,233%

FAQ

What is 4D Molecular Therapeutics's deferred revenue — deferred revenue?

4D Molecular Therapeutics (FDMT) reported deferred revenue — deferred revenue of $2.49M in Q1 2026.

What does deferred revenue — deferred revenue mean?

This metric represents the portion of consideration received from customers for which the company has not yet satisfied its performance obligations under gene therapy development or collaboration agreements. It reflects future revenue that will be recognized as the company fulfills its contractual milestones or service delivery requirements. Monitoring this balance provides insight into the timing of revenue recognition and the progress of long-term research and development partnerships.